Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • giorgifm
    Member
    • Aug 2011
    • 35

    Coverage "standards" for SNP detection in tumor samples

    Dear all,

    I was wondering if there is a standard "coverage" for exomic SNP calling in tumor_vs_healthy samples (same patient). As we know, tumor samples have an intrinsically higher mutability (Parsons et al., 1993). I was thinking of applying a threshold of at least 20X for the healthy one, and 50X for the tumor one. Do these look sufficient to you?

    Also, there appears to be no standard for coverage definition: so by "50X" I intend exome-wise coverage of 100bp uniquely-mapping Illumina paired reads, after duplicate removal.

    Thanks!

    Federico
  • Bukowski
    Senior Member
    • Jan 2010
    • 388

    #2
    Originally posted by giorgifm View Post
    Dear all,

    I was wondering if there is a standard "coverage" for exomic SNP calling in tumor_vs_healthy samples (same patient). As we know, tumor samples have an intrinsically higher mutability (Parsons et al., 1993). I was thinking of applying a threshold of at least 20X for the healthy one, and 50X for the tumor one. Do these look sufficient to you?

    Also, there appears to be no standard for coverage definition: so by "50X" I intend exome-wise coverage of 100bp uniquely-mapping Illumina paired reads, after duplicate removal.

    Thanks!

    Federico
    No there is no standard. It depends how many calls you want to make accurately. Something like SomaticSniper will happily call things in low coverage areas, but you will have little confidence in the genotypes. Even with 40x coverage for an exome sample.

    I'm doing some development work on cancer panels, and we've been advised (this is not exome sequencing, but targetted resequencing) to be aiming for 500x to 1000x coverage. I was a little iffy about these figures until I started actually doing the analysis on exomes myself just to test things out.

    This is prohibitively expensive for exomes I imagine, so I think in terms of depth 'as much as you can afford'. Remember you will also want to be confident about the genotype calls in your normal samples..

    Comment

    • giorgifm
      Member
      • Aug 2011
      • 35

      #3
      Thank you for your answer Bukowski. So far we are aiming at around 40x coverage. That seems to be the minimum coverage to stabilize the significance of somatic mutations found.

      Comment

      • rama
        Member
        • Jan 2011
        • 20

        #4
        finding the depth of coverage with more confidence

        This is an extension to the original question on this post. I was wondering if anybody knows how I can calculate the accuracy in sequencing at various levels of depth of coverage. based on this I want to choose the coverage with more confidence. thanks in advance to all.

        Comment

        • Heisman
          Senior Member
          • Dec 2010
          • 534

          #5
          Originally posted by rama View Post
          This is an extension to the original question on this post. I was wondering if anybody knows how I can calculate the accuracy in sequencing at various levels of depth of coverage. based on this I want to choose the coverage with more confidence. thanks in advance to all.
          A couple ideas: http://genome.sph.umich.edu/wiki/SNP...Set_Properties

          Also, for any metric, you can tentatively assume your higher coverage/higher quality score calls will be more "correct" than the lower coverage/lower quality score calls. Thus, for any metric, compare different coverage thresholds to your highest quality sets. One caveat is it's possible for mapping artifacts or other things to lead to super high coverage, so make sure your "high quality set" looks real.

          Comment

          • rama
            Member
            • Jan 2011
            • 20

            #6
            Thanks a bunch for the pointer.
            once we identify the data with "high quality set" is there a way to compute metrics at different coverage thresholds. I am not sure how to do it, do I have to randomly subset sequence reads and check for the variant calls or just compare with the consensus?

            Comment

            • Joann
              Senior Member
              • Oct 2008
              • 230

              #7
              Global Alliance White Paper on Clinical Data

              There is a consortium on clinical data as described in the White Paper linked here:



              On page 30 there is listed the names of organizers and their institutions, where you may be able to obtain additional follow-up information to "standards" questions about clinical data at this time.

              Please contribute your posts on any standards statements that you may obtain therefrom here at this forum and/or in the Wiki so that others may be kept informed thus enabling a more rapid dissemination of consensus parameters.

              Comment

              • Heisman
                Senior Member
                • Dec 2010
                • 534

                #8
                Originally posted by rama View Post
                Thanks a bunch for the pointer.
                once we identify the data with "high quality set" is there a way to compute metrics at different coverage thresholds. I am not sure how to do it, do I have to randomly subset sequence reads and check for the variant calls or just compare with the consensus?
                I was thinking just separate calls by coverage. IE, make a set of calls at >100x coverage, a set at 90-100x, a set at 80-90x, etc, and compare them. Or use quality score instead of coverage if you like that metric better. Your idea is interesting though; you could take a set of high quality calls and then randomly take smaller and smaller sets of reads for the same positions, redo the calling, and see how low the coverage threshold can get until your "subset calls" deviate too much from the legitimate set. The problem is if your high quality calls are in "easy" sites then this strategy won't apply to the rest of the genome necessarily.

                Comment

                Latest Articles

                Collapse

                • SEQadmin2
                  Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
                  by SEQadmin2



                  Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
                  ...
                  Today, 11:10 AM
                • SEQadmin2
                  Cancer Drug Resistance: The Lingering Barrier to Rising Survival
                  by SEQadmin2



                  Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

                  There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
                  Yesterday, 05:17 AM
                • GATTACAT
                  Reply to Nine Things a Sample Prep Scientist Thinks About Before Sequencing
                  by GATTACAT
                  Love this - good data definitely starts from good input, and poor input can only give relatively poor data. I particularly like the mention of Nanodrop/absorbance based methods for quantification. It's such a toss up if you'll get an accurate reading or what amounts to a randomly generated number, and a lot of library/sequencing related issues can be traced back to poor quant.
                  07-01-2026, 11:43 AM

                ad_right_rmr

                Collapse

                News

                Collapse

                Topics Statistics Last Post
                Started by SEQadmin2, Today, 10:04 AM
                0 responses
                8 views
                0 reactions
                Last Post SEQadmin2  
                Started by SEQadmin2, Yesterday, 10:08 AM
                0 responses
                7 views
                0 reactions
                Last Post SEQadmin2  
                Started by SEQadmin2, 07-07-2026, 11:05 AM
                0 responses
                9 views
                0 reactions
                Last Post SEQadmin2  
                Started by SEQadmin2, 07-02-2026, 11:08 AM
                0 responses
                31 views
                0 reactions
                Last Post SEQadmin2  
                Working...